Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion. The Financial Times first revealed the ...

Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...

Roche has made another MAGE-A4 program disappear, withdrawing a phase 1 trial of a T-cell bispecific prospect before a single patient was enrolled. The withdrawal, which ApexOnco reported earlier ...

Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...

DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today. The company’s shares closed today at $321.00. Kraus covers the Healthcare sector ...

Heather Locklear Mourns the Loss of Her 'Brilliant' Father Bill: 'Love of My Life' Jack Wagner Says He'd 'Absolutely Entertain' a Cameo on Melrose Place Revival: 'You Never Really Die on a Soap ...

Roche’s new TAGS technology overcomes the technical limitations of a typical 4-plex test result in previous solutions, using a novel, proprietary approach. Without having to upgrade hardware or ...

Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...

About the interviewee Heather Moses will be speaking at the 2019 eyeforpharma conference in Barcelona in March. Moses is head of medical affairs within the UK at Roche. She plays a key role on ...

Mental healthcare is healthcare—and insurers need to get with the program.

Skin care aficionados everywhere are making space for a dermatologist-backed, budget-friendly brand in their medicine ...